Cargando…
Cerebellar and brainstem stroke possibly associated with booster dose of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine
As COVID-19 vaccination becomes widely available and administered globally, there have been several reports of side effects attributed to the vaccine. This report highlights a patient who developed stroke 2 days following the administration of the COVID-19 vaccine, although its association remains u...
Autores principales: | Thomas, Michael George, Dermawan, Andrew, Teh, Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163425/ https://www.ncbi.nlm.nih.gov/pubmed/37147105 http://dx.doi.org/10.1136/bcr-2022-251180 |
Ejemplares similares
-
Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine
por: Muhamad Fauzi, Siti Mardhiah
Publicado: (2023) -
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
por: Qureshi, Muhammad Imran Ahmad, et al.
Publicado: (2022) -
Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
por: Gill, Rahul, et al.
Publicado: (2022) -
A racing heart post‐Pfizer/BioNTech BNT162b2
por: Teo, Hooi Khee, et al.
Publicado: (2022) -
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
por: Hamada, Yohhei
Publicado: (2021)